Berkshire Likes Express Scripts--and So Do We
The wide-moat pharmacy benefit manager--which is currently rated 4 stars by Morningstar--was Berkshire's only new money purchase during the third quarter.
The wide-moat pharmacy benefit manager--which is currently rated 4 stars by Morningstar--was Berkshire's only new money purchase during the third quarter.
While wide-moat Berkshire Hathaway's (BRK.B) third-quarter 13-F filing was overshadowed this week by the firm's announcement that it would be exchanging its 52.8 million share stake in Procter & Gamble (PG) (worth $4.7 billion) for the Duracell battery business, the company did report some changes to the stock portfolio (that look to be more the work of Todd Combs and Ted Weschler than Warren Buffett).
Berkshire's 13-F equity holdings, which do not include foreign investments held abroad like BYD and Tesco, were valued at $107.8 billion at the end of the third quarter, with the top five holdings-- Wells Fargo (WFC) (22%), Coke (KO) (16%), American Express (AXP) (12%), IBM (IBM) (12%), and Wal-Mart Stores (WMT) (4%)--accounting for more than two thirds of the portfolio.
The insurer's only new money purchase during the period was 450,000 shares of Express Scripts for an estimated cost of around $32 million. Berkshire also more than doubled its stake in Charter Communications (CHTR) (making it a $750 million holding), and made meaningful additions to its stakes in DirecTV , General Motors (GM), Visa (V), and MasterCard (MA). (The last two purchases look to be fairly prescient, as both stocks have risen more than 15% since the start of the fourth quarter.) The company also held 8 million shares of Liberty Media Class C (LMCK), which was paid out during the period as a stock dividend on Berkshire's holdings in Liberty Media Class A (LMCA) shares.
As for the sales reported for the third quarter, the firm eliminated its stake in Deere (DE) (netting an estimated $340 million), and unloaded close to two thirds of its holdings in ConocoPhillips (COP) (for $70 million), 920,000 shares of National Oilwell Varco (NOV) ($70 million), 1.3 million shares of Bank of New York Mellon (BK) ($50 million), and 290,000 shares of Phillips 66 (PSX) ($25 million).
As always, the quarterly share changes in Berkshire's stock portfolio have no real impact on our fair value estimate for the firm, which continues to be driven to a large degree by the performance of its operating businesses.
Morningstar Premium Members gain exclusive access to our full Berkshire Hathaway analyst report, including fair value estimates, consider buying/selling prices, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.
Greggory Warren does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals
and individual investors. These products and services are usually sold through
license agreements or subscriptions. Our investment management business generates
asset-based fees, which are calculated as a percentage of assets under management.
We also sell both admissions and sponsorship packages for our investment conferences
and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.